Ditchcarbon
  • Contact
  1. Organizations
  2. Glaxosmithkline Biologicals S.A.
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
BE
updated a month ago

Glaxosmithkline Biologicals S.A.

Company website

GlaxoSmithKline Biologicals S.A., commonly referred to as GSK Biologicals, is a leading global player in the biopharmaceutical industry, headquartered in Belgium. Founded in 1995, the company has established itself as a pioneer in vaccine development, focusing on innovative solutions to combat infectious diseases. With a strong operational presence across Europe, North America, and emerging markets, GSK Biologicals is dedicated to enhancing public health through its extensive portfolio of vaccines. The company’s core offerings include vaccines for diseases such as influenza, hepatitis, and meningitis, distinguished by their advanced research and development processes. GSK Biologicals has achieved notable milestones, including the introduction of several groundbreaking vaccines that have significantly impacted global health. As a subsidiary of GlaxoSmithKline plc, it continues to maintain a robust market position, recognised for its commitment to quality and innovation in the biopharmaceutical sector.

DitchCarbon Score

How does Glaxosmithkline Biologicals S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

100

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Glaxosmithkline Biologicals S.A.'s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

100%

Let us know if this data was useful to you

Glaxosmithkline Biologicals S.A.'s reported carbon emissions

Inherited from GSK plc

Glaxosmithkline Biologicals S.A., headquartered in Belgium (BE), currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of GSK plc, which may influence its climate commitments and initiatives. While specific reduction targets or achievements are not detailed, Glaxosmithkline Biologicals S.A. aligns its climate strategies with those of its parent company, GSK plc. This includes participation in various sustainability initiatives such as the Science Based Targets initiative (SBTi), CDP, RE100, and the Climate Pledge, all of which are cascaded from GSK plc. These initiatives aim to enhance transparency and accountability in reducing carbon emissions across their operations. As a part of GSK plc's broader climate strategy, Glaxosmithkline Biologicals S.A. is expected to contribute to the overarching goals of reducing greenhouse gas emissions and promoting sustainable practices within the pharmaceutical industry. However, specific metrics or targets for Glaxosmithkline Biologicals S.A. have not been disclosed at this time.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20142015201620172018201920202021202220232024
Scope 1
851,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
745,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
00,000,000
00,000,000
Scope 3
16,093,000,000
00,000,000,000
00,000,000,000
00,000,000,000
00,000,000,000
-
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Glaxosmithkline Biologicals S.A.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Glaxosmithkline Biologicals S.A. is in BE, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Glaxosmithkline Biologicals S.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Dynavax Technologies Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Csl

AU
•
Pharmaceutical Preparation Manufacturing
Updated 6 minutes ago

Hookipa Biotech AG

AT
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Janssen

US
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Mitsubishi Tanabe Pharma

JP
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251007.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy